Antoine Espinet

Antoine Espinet is the co-founder and CEO of MFX, a company at Stevenage Bioscience Catalyst developing instrumentation for early-stage cell therapy process work. MFX has built the Development Engine, a closed, parallelised system that brings continuous online monitoring — dissolved oxygen, pH, Raman spectroscopy and multiplane imaging — into process development, with cassette geometry that scales linearly from bench to manufacturing without re-optimisation. Antoine started the company after five years as a management consultant at McKinsey, and holds a PhD in Engineering from Cornell University.